Comparing Certara (NASDAQ:CERT) & NortonLifeLock (NASDAQ:NLOK)

Certara (NASDAQ:CERTGet Rating) and NortonLifeLock (NASDAQ:NLOKGet Rating) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, analyst recommendations, institutional ownership and risk.

Institutional and Insider Ownership

52.1% of Certara shares are held by institutional investors. Comparatively, 94.6% of NortonLifeLock shares are held by institutional investors. 4.0% of Certara shares are held by insiders. Comparatively, 3.2% of NortonLifeLock shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Certara and NortonLifeLock’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Certara $286.10 million 10.67 -$13.27 million ($0.08) -238.75
NortonLifeLock $2.80 billion 4.98 $836.00 million $1.41 16.99

NortonLifeLock has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than NortonLifeLock, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Certara has a beta of 1.55, meaning that its share price is 55% more volatile than the S&P 500. Comparatively, NortonLifeLock has a beta of 0.65, meaning that its share price is 35% less volatile than the S&P 500.

Profitability

This table compares Certara and NortonLifeLock’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Certara -4.02% 3.65% 2.48%
NortonLifeLock 29.90% -444.77% 15.09%

Analyst Ratings

This is a breakdown of current ratings and target prices for Certara and NortonLifeLock, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Certara 0 1 3 0 2.75
NortonLifeLock 0 3 2 0 2.40

Certara presently has a consensus price target of $30.75, suggesting a potential upside of 60.99%. NortonLifeLock has a consensus price target of $28.20, suggesting a potential upside of 17.75%. Given Certara’s stronger consensus rating and higher possible upside, research analysts clearly believe Certara is more favorable than NortonLifeLock.

About Certara (Get Rating)

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.

About NortonLifeLock (Get Rating)

NortonLifeLock Inc. provides cyber safety solutions for consumers worldwide. The company offers Norton 360, an integrated platform provides extensive cyber safety coverage and a subscription service providing protection for PCs, Macs, and mobile devices against malware, viruses, adware, ransomware, and other online threats on various platforms; and LifeLock identity theft protection solution that offers monitoring, alerts, and restoration services to its customers. It also provides Norton Secure VPN solution enhances security and online privacy by providing an encrypted data tunnel; Privacy Monitor Assistant, an on-demand, white glove service where agents help members delete personal information from data brokers online; Home Title Protect product detects fraud and notifies members; and Avira Security, a consumer-focused portfolio of cybersecurity and privacy solutions. The company markets and sells its products and related services through retailers, telecom service providers, hardware original equipment manufacturers, and employee benefit providers, as well as e-commerce platform. It operates in the United States, Canada, Latin America, Europe, the Middle East, Africa, the Asia Pacific, and Japan. The company was formerly known as Symantec Corporation and changed its name to NortonLifeLock Inc. in November 2019. NortonLifeLock Inc. was founded in 1982 and is headquartered in Tempe, Arizona.

Receive News & Ratings for Certara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Certara and related companies with MarketBeat.com's FREE daily email newsletter.